My apologies for saying limit of 10% daily volume.
Yesterday's buyback volume is way higher than I expected.
The high buyback means the board believes current share price is undervalued.
Current cash position is around $210m, royalties payment plus bank interest are around $18m, which is about to cover current expenditure. However the expenditure should increase as PMS proceeds to the Phase 3 trial next year, imo. NEU is to receive additional US$100m next quarter, so cash position will be well above $300m. I won't be surprised if the share buyback is upsized at next AGM in May 2025.
All imo.
- Forums
- ASX - By Stock
- NEU Vs Reata
NEU
neuren pharmaceuticals limited
Add to My Watchlist
0.92%
!
$14.33

My apologies for saying limit of 10% daily volume. Yesterday's...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$14.33 |
Change
0.130(0.92%) |
Mkt cap ! $1.770B |
Open | High | Low | Value | Volume |
$14.23 | $14.71 | $14.03 | $2.704M | 189.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
10 | 131 | $14.32 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$14.34 | 77 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 55 | 14.320 |
4 | 273 | 14.310 |
5 | 472 | 14.300 |
5 | 1172 | 14.290 |
5 | 1334 | 14.280 |
Price($) | Vol. | No. |
---|---|---|
14.330 | 48 | 2 |
14.340 | 268 | 7 |
14.350 | 500 | 4 |
14.360 | 1740 | 8 |
14.370 | 1161 | 5 |
Last trade - 12.25pm 30/06/2025 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online